Loading...
Utility of (18)FLT-PET to Assess Treatment Response in Trastuzumab-resistant and Sensitive HER2-overexpressingHuman Breast Cancer Xenografts
PURPOSE: Evaluate 3’-deoxy-3’-[(18)F]-fluorothymidine ((18)FLT) PET as an early marker of trastuzumab response in HER2-overexpressing xenografts. PROCEDURES: Tumor-to-muscle ratios were compared between both trastuzumab-sensitive and resistant cohorts prior to and after one and two treatments. RESUL...
Na minha lista:
| Udgivet i: | Mol Imaging Biol |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4311727/ https://ncbi.nlm.nih.gov/pubmed/25034624 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11307-014-0770-z |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|